TREVI THERAPEUTICS INC TRVI

US Healthcare Pharmaceutical Preparations
$17.93
+1.8%
52w: $5.47 – $18.65

Latest 13F among current holders filed 31 days ago (Jun 4, 2026)

Price — last 12 months

research preview data
5.4712.0618.65
Jun 20, 2025 Jul 2, 2026
Institutional holders
199
+14 QoQ
13F value
$1.61B
-1.0% QoQ
Smart-money holders
31
signal tier ≥ 2
New smart buyers
5
Q1 2026
Options barometer
2.0×
$11.1M calls / $5.7M puts

Institutional value by quarter

$180.5M
Q1 2024
$175.0M
Q2 2024
$194.5M
Q3 2024
$329.5M
Q4 2024
$554.5M
Q1 2025
$631.7M
Q2 2025
$1.18B
Q3 2025
$1.63B
Q4 2025
$1.61B
Q1 2026

Number of holders

81
Q1 2024
78
Q2 2024
94
Q3 2024
111
Q4 2024
138
Q1 2025
155
Q2 2025
164
Q3 2025
185
Q4 2025
199
Q1 2026

Who owns TRVI?

Q1 2026 filings
FundTypeSharesValue% of fundChange
NEA Management Company, LLC ★3Fundamental concentrated13.2M$157.7M9.0%Held
BlackRock, Inc. Index provider10.2M$122.2M0.0%+1.1%
Frazier Life Sciences Management, L.P. ★3Fundamental concentrated9.9M$118.6M3.1%-3.1%
FMR LLC Long only active8.0M$95.9M0.0%+23.7%
WELLINGTON MANAGEMENT GROUP LLP Long only active5.2M$61.9M0.0%+52.4%
Vivo Capital, LLC ★3Fundamental concentrated5.1M$60.8M5.1%Held
VANGUARD CAPITAL MANAGEMENT LLC Diversified mechanical5.0M$59.4M0.0%
MARSHALL WACE, LLP Quant stat arb4.0M$47.3M0.1%-13.4%
Rubric Capital Management LP ★2Fundamental diversified3.7M$44.3M0.5%-1.4%
MPM BIOIMPACT LLC ★2Fundamental concentrated3.3M$39.4M3.0%+0.3%
VIKING GLOBAL INVESTORS LP ★2Fundamental diversified3.2M$38.2M0.1%Held
ALLIANCEBERNSTEIN L.P. Long only active2.8M$35.6M0.0%-7.7%
GEODE CAPITAL MANAGEMENT, LLC Index provider2.8M$33.2M0.0%+15.1%
STATE STREET CORP Index provider2.7M$31.8M0.0%+9.5%
EVENTIDE ASSET MANAGEMENT, LLC Other2.6M$31.3M0.5%Held
ORBIMED ADVISORS LLC ★2Fundamental diversified2.5M$29.3M0.7%-23.1%
Logos Global Management LP ★2Fundamental concentrated2.4M$28.6M1.5%+54.8%
Vestal Point Capital, LP ★2Fundamental diversified2.2M$25.8M0.7%New
ACORN CAPITAL ADVISORS, LLC ★3Fundamental concentrated2.1M$25.6M7.3%Held
Artia Global Partners LP ★2Fundamental concentrated2.0M$24.0M5.4%Held
Affinity Asset Advisors, LLC ★2Fundamental diversified2.0M$23.9M1.4%-7.0%
FRONTIER CAPITAL MANAGEMENT CO LLC Other2.0M$23.8M0.2%+79.9%
EMERALD ADVISERS, LLC Other1.8M$21.9M0.7%-2.8%
Siren, L.L.C. ★2Fundamental diversified1.8M$21.3M0.6%-21.9%
Pictet Asset Management Holding SA Diversified mechanical1.7M$20.4M0.0%+11.4%
RAYMOND JAMES FINANCIAL INC Bank broker1.7M$20.1M0.0%-4.5%
Soleus Capital Management, L.P. ★2Fundamental diversified1.6M$19.3M0.8%+80.0%
Pivotal bioVenture Partners Investment Advisor LLC ★3Fundamental concentrated1.6M$18.5M6.6%+23.6%
Octagon Capital Advisors LP ★2Fundamental concentrated1.5M$17.7M2.0%-47.2%
EMERALD MUTUAL FUND ADVISERS TRUST Other1.3M$15.1M0.7%-0.8%
GOLDMAN SACHS GROUP INC Bank broker1.2M$14.6M0.0%+16.2%
BANK OF AMERICA CORP /DE/ Bank broker1.2M$14.5M0.0%+11.2%
CITADEL ADVISORS LLC Multistrat pod1.2M$14.3M0.0%+686.0%
NAN FUNG TRINITY (HK) LTD ★2Fundamental concentrated1.1M$13.6M1.5%+24.6%
FLPUTNAM INVESTMENT MANAGEMENT CO Other1.1M$12.7M0.2%+0.9%
Woodline Partners LP Other1.0M$11.9M0.0%0.0%
VANGUARD PORTFOLIO MANAGEMENT LLC Diversified mechanical968.6K$11.6M0.0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC Index provider840.6K$10.0M0.0%+0.5%
NORTHERN TRUST CORP Index provider806.7K$9.6M0.0%+5.9%
Candriam S.C.A. Other773.6K$9.2M0.0%New
MORGAN STANLEY Bank broker731.3K$8.7M0.0%-30.4%
VANGUARD FIDUCIARY TRUST CO Diversified mechanical714.6K$8.5M0.0%
PANAGORA ASSET MANAGEMENT INC Diversified mechanical625.6K$7.5M0.0%-9.7%
SPHERA FUNDS MANAGEMENT LTD. Other574.0K$6.8M1.2%-4.1%
MILLENNIUM MANAGEMENT LLC Multistrat pod571.0K$6.8M0.0%+0.1%
PEREGRINE CAPITAL MANAGEMENT LLC Other530.5K$6.3M0.2%+4.5%
Burkehill Global Management, LP Quant stat arb525.0K$6.3M0.3%Held
SILVERARC CAPITAL MANAGEMENT, LLC ★2Fundamental diversified511.1K$6.1M0.7%-5.6%
AMERIPRISE FINANCIAL INC Bank broker504.8K$6.0M0.0%+55.7%
Balyasny Asset Management L.P. Multistrat pod473.8K$5.7M0.0%+171.3%

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.